Chemopreventive effect of fish oil derived EPA in lung cancer
鱼油衍生的 EPA 对肺癌的化学预防作用
基本信息
- 批准号:8467989
- 负责人:
- 金额:$ 29.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:A/J MouseA549AdenocarcinomaAdverse effectsAffectAnimal ModelAnimalsArachidonic AcidsAspirinBenignBindingBiologicalCancer ControlCancer EtiologyCancer ModelCardiotoxicityCardiovascular systemCause of DeathCell LineCessation of lifeChemopreventionChemopreventive AgentColon CarcinomaConsumptionCoxibsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclooxygenase InhibitorsDataDevelopmentDietDinoprostoneDocosahexaenoic AcidsDoseEP4 receptorEicosapentaenoic AcidEnzymesEpidemiologic StudiesEpidermal Growth Factor ReceptorEpithelial CellsFDA approvedFVB MouseFish OilsFishesGoalsGrowthGrowth and Development functionH1299Heart DiseasesHumanHuman DevelopmentIn VitroIncidenceIndomethacinInflammation MediatorsInflammatoryKnockout MiceLOX geneLesionLinkLungLung AdenocarcinomaLung AdenomaLung NeoplasmsMAP Kinase GeneMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMediatingMembraneMetabolismMethodsModelingMolecularMolecular TargetMusMutationNon-Small-Cell Lung CarcinomaNon-Steroidal Anti-Inflammatory AgentsOmega-3 Fatty AcidsPathway interactionsPatientsPeripheral Blood Mononuclear CellPharmacodynamicsPharmacologic SubstancePhospholipidsPolyunsaturated Fatty AcidsPopulationPremalignantPreventionPrevention strategyProtein ArrayRelative (related person)ResearchResearch Project GrantsRiskRoleSamplingSeriesSignal PathwaySignal TransductionSmall Interfering RNASmokerStructure of parenchyma of lungSupplementationSurvival RateTarget PopulationsTestingTransgenic MiceTranslatingTumor TissueUp-RegulationUrethaneVariantWestern BlottingWomanWorkanticancer activitybasecancer cellcancer preventioncancer therapycarcinogenesiscelecoxibcellular engineeringchemotherapycyclooxygenase 2dietary supplementseicosanoid metabolismfeedinghigh riskhuman WFDC2 proteinimprovedin vivoinhibitor/antagonistinsightlung cancer preventionlung carcinogenesismalignant breast neoplasmmenneoplastic cellnoveloutcome forecastoverexpressionpatient populationphase 2 studypre-clinicalpreventprostaglandin E3prostaglandin EP2 receptorprotective effectpublic health relevancereceptorresearch clinical testingresearch studyresponsesmoking cessationtreatment strategytumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Lung cancer is the single greatest cause of death from malignancy in both men and women in the US, exceeding that of the next three combined leading ncers (prostate, colon and breast cancer). Although smoking cessation is a key to lung cancer prevention, it remains a challenge. Finding effective preventive and treatment strategies for lung cancer are desperately needed. Cyclooygenase-2 (COX-2), a key mediator of inflammation, is an important target for lung cancer therapy and prevention because approximately 70% of lung adenocarcinomas have overexpression of COX-2 and regular use of aspirin and other NSAIDs is associated with a reduced risk of developing lung cancer in animal models and smokers. Regardless of the cardiac toxicity of selective COX-2 inhibitors, a growing body of evidence supports the etiological impact of COX-2 in lung cancer. Fish oil represents an attractive series of n-3 fatty acids (eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids) that modulate COX-2 activity while having beneficial cardiovascular effects. The strong link between COX-2 and fish oil-induced chemoprevention has been strengthen by recent findings of high consumption of long chain n-3 fatty acids lowering their risk of prostate cancer and this protective effect being more pronounced in men carrying a particular COX-2 variant. The ultimate goal of this proposal is to define the optimal dose of EPA and relevant fish oil products to maximize the chemopreventive effects of fish oil against human lung cancer and to identify an appropriate molecular target of fish oil for prevention of lung cancer. We will determine the chemopreventive role of EPA and fish oils using a urethane- induced mouse lung cancer model with and without expression of COX-2, as well as the K-ras mutation mouse lung model. We will also evaluate the molecular mechanisms associated with EPA-induced tumor growth suppression by studying the biological effects of PGE2 and the EPA metabolite PGE3 in premalignant and lung cancer cells and their interaction with PGE2 receptors. The critical role of EPA-derived PGE3 in lung cancer prevention using the urethane-induced mouse lung cancer model with or without expression of EP receptor, particularly EP2 and EP4 receptors, will be further studied. This proposal intends to define a novel targeted natural chemopreventive agent against lung cancer.
描述(由申请人提供):肺癌是美国男性和女性的恶性死亡原因,超过了接下来的三个联合主要NCER(前列腺,结肠癌和乳腺癌)。尽管戒烟是预防肺癌的关键,但仍然是一个挑战。迫切需要寻找有效的肺癌预防和治疗策略。环氧酶-2(COX-2)是炎症的关键介体,是肺癌疗法和预防的重要靶标,因为大约70%的肺腺癌的肺腺癌过度表达了COX-2,并且定期使用阿司匹林和其他NSAID与动物模型和吸烟者中肺癌发展的风险降低有关。不管选择性COX-2抑制剂的心脏毒性如何,越来越多的证据支持COX-2对肺癌的病因影响。鱼油代表了一系列有吸引力的N-3脂肪酸(Eicosapentaenoic(EPA)和Docosahecahexaenoic(DHA)酸),可调节COX-2活性,同时具有有益的心血管效应。最近发现,长链N-3脂肪酸降低了前列腺癌的风险,COX-2与鱼油诱导的化学预防之间的牢固联系得到了加强,并且这种保护作用在携带特定Cox-2变体的男性中更为明显。该提案的最终目标是定义EPA和相关鱼油产品的最佳剂量,以最大程度地提高鱼油对人肺癌的化学预防作用,并确定鱼油的适当分子靶标,以预防肺癌。我们将使用氨基甲酸酯诱导的小鼠肺癌模型和具有COX-2表达的小鼠肺癌模型以及K-RAS突变小鼠肺模型来确定EPA和鱼油的化学预防作用。我们还将通过研究PGE2和EPA代谢产物PGE3在预抗癌前和肺癌细胞中的生物学作用以及它们与PGE2受体的相互作用来评估与EPA诱导的肿瘤生长抑制相关的分子机制。 EPA衍生的PGE3在使用氨基甲酸酯诱导的小鼠肺癌模型(或不表达EP受体,尤其是EP2和EP4受体的表达)中的关键作用将进一步研究。该提案旨在定义一种针对肺癌的新型靶向天然化学预防剂。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prostaglandin E3 metabolism and cancer.
- DOI:10.1016/j.canlet.2014.03.010
- 发表时间:2014-06-28
- 期刊:
- 影响因子:9.7
- 作者:Yang, Peiying;Jiang, Yan;Fischer, Susan M.
- 通讯作者:Fischer, Susan M.
Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.
- DOI:10.1371/journal.pone.0061379
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Pirman DA;Efuet E;Ding XP;Pan Y;Tan L;Fischer SM;DuBois RN;Yang P
- 通讯作者:Yang P
Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
- DOI:10.1002/mc.22008
- 发表时间:2014-07
- 期刊:
- 影响因子:4.6
- 作者:Yang, Peiying;Cartwright, Carrie;Chan, Diana;Ding, Jibin;Felix, Edward;Pan, Yong;Pang, Jihai;Rhea, Patrea;Block, Keith;Fischer, Susan M.;Newman, Robert A.
- 通讯作者:Newman, Robert A.
Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
- DOI:10.18632/oncotarget.5558
- 发表时间:2015-11-17
- 期刊:
- 影响因子:0
- 作者:Pan Y;Jiang Y;Tan L;Ravoori MK;Gagea M;Kundra V;Fischer SM;Yang P
- 通讯作者:Yang P
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PEIYING YANG其他文献
PEIYING YANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PEIYING YANG', 18)}}的其他基金
Chemopreventive effect of fish oil derived EPA in lung cancer
鱼油衍生的 EPA 对肺癌的化学预防作用
- 批准号:
8088143 - 财政年份:2010
- 资助金额:
$ 29.89万 - 项目类别:
Chemopreventive effect of fish oil derived EPA in lung cancer
鱼油衍生的 EPA 对肺癌的化学预防作用
- 批准号:
8245134 - 财政年份:2010
- 资助金额:
$ 29.89万 - 项目类别:
Sweet gum extract and late stage prostate cancer
枫香提取物与晚期前列腺癌
- 批准号:
7530841 - 财政年份:2008
- 资助金额:
$ 29.89万 - 项目类别:
Sweet gum extract and late stage prostate cancer
枫香提取物与晚期前列腺癌
- 批准号:
7683276 - 财政年份:2008
- 资助金额:
$ 29.89万 - 项目类别:
相似国自然基金
一个肺腺癌相关新lncRNA LOC100132354的生物学功能及其分子机制研究
- 批准号:81401736
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
弓形虫ROP16蛋白介导人肺腺癌细胞JAK-STAT途径调节其生物表型的研究
- 批准号:81301945
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Id3在肺腺癌中的表达分析及其对A549肺腺癌细胞增殖影响的机制研究
- 批准号:81171652
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
姜黄素调控肺腺癌A549细胞株SP细胞Wnt信号通路的研究
- 批准号:81001578
- 批准年份:2010
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
化毒补虚法对肺癌Survivin基因及相关凋亡机制调控的分子机制研究
- 批准号:81072757
- 批准年份:2010
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
走向临床试验:AXL-STAT3 靶向肺肿瘤微环境
- 批准号:
10660429 - 财政年份:2023
- 资助金额:
$ 29.89万 - 项目类别:
Antitumor potential of AvFc lectibody in non-small cell lung cancer
AvFc 凝集体在非小细胞肺癌中的抗肿瘤潜力
- 批准号:
10717195 - 财政年份:2023
- 资助金额:
$ 29.89万 - 项目类别:
Computationally Guided Approach to Produce Ratiometric Probes Operating in the Red to Near-infrared Region to Accurately Determine pH Levels within Organelles
计算引导方法生产在红色至近红外区域运行的比率探针,以准确确定细胞器内的 pH 水平
- 批准号:
10796036 - 财政年份:2023
- 资助金额:
$ 29.89万 - 项目类别:
Novel strategies to target lung cancer metastasis to bone
针对肺癌骨转移的新策略
- 批准号:
10646351 - 财政年份:2022
- 资助金额:
$ 29.89万 - 项目类别: